Download AQA JUNE 2022 BIOLOGY AS LEVEL 7401 PAPER 1 MARKSHEME MS and more Exams Biology in PDF only on Docsity!
AQA JUNE 2022 BIOLOGY AS LEVEL7401 PAPER 1 MARKSHEME MS
AQA JUNE 2022
BIOLOGY AS LEVEL
7401 PAPER 1
MARKSHEME MS
AS
BIOLOGY
7401/
Paper 1
Mark scheme
June 2022
Version: 1.0 Final
226A7401/1/MS
Mark schemes are prepared by the Lead Assessment Writer and considered, together with the relevant questions, by a panel of subject teachers. This mark scheme includes any amendments made at the standardisation events which all associates participate in and is the scheme which was used by them in this examination. The standardisation process ensures that the mark scheme covers the students’ responses to questions and that every associate understands and applies it in the same correct way. As preparation for standardisation each associate analyses a number of students’ scripts. Alternative answers not already covered by the mark scheme are discussed and legislated for. If, after the standardisation process, associates encounter unusual answers which have not been raised they are required to refer these to the Lead Examiner. It must be stressed that a mark scheme is a working document, in many cases further developed and expanded on the basis of students’ reactions to a particular paper. Assumptions about future mark schemes on the basis of one year’s document should be avoided; whilst the guiding principles of assessment remain constant, details will change, depending on the content of a particular examination paper. Further copies of this mark scheme are available from aqa.org.uk Copyright information AQA retains the copyright on all its publications. However, registered schools/colleges for AQA are permitted to copy material from this booklet for their own internal use, with the following important exception: AQA cannot give permission to schools/colleges to photocopy any material that is acknowledged to a third party even for internal use within the centre. Copyright © 2022 AQA and its licensors. All rights reserved.
Mark scheme instructions to examiners
1. General
The mark scheme for each question shows:
- the marks available for each part of the question
- the total marks available for the question
- the typical answer or answers which are expected
- Extra information to help the examiner make his or her judgement and help to delineate what is acceptable or not worthy of credit or, in discursive answers, to give an overview of the area in which a mark or marks may be awarded. The extra information in the ‘Comments’ column is aligned to the appropriate answer in the left- hand part of the mark scheme and should only be applied to that item in the mark scheme. At the beginning of a part of a question a reminder may be given, for example: where consequential marking needs to be considered in a calculation; or the answer may be on the diagram or at a different place on the script. In general the right-hand side of the mark scheme is there to provide those extra details which confuse the main part of the mark scheme yet may be helpful in ensuring that marking is straightforward and consistent.
2. Emboldening
2.1 In a list of acceptable answers where more than one mark is available ‘any two from’ is used, with the number of marks emboldened. Each of the following bullet points is a potential mark. 2.2 A bold and is used to indicate that both parts of the answer are required to award the mark. 2.3 Alternative answers acceptable for the same mark are indicated by the use of OR. Different terms in the mark scheme are shown by a/; eg allow smooth/free movement.
3. Marking points
3.1 Marking of lists
This applies to questions requiring a set number of responses, but for which students have provided extra responses. The general principle to be followed in such a situation is that ‘right + wrong = wrong’. Each error/contradiction negates each correct response. So, if the number of errors/contradictions equals or exceeds the number of marks available for the question, no marks can be awarded. However, responses considered to be neutral (often prefaced by ‘Ignore’ in the ‘Comments’ column of the mark scheme) are not penalised.
3.2 Marking procedure for calculations
Full marks can be given for a correct numerical answer, without any working shown. However, if the answer is incorrect, mark(s) can usually be gained by correct substitution/working and this is shown in the ‘Comments’ column or by each stage of a longer calculation.
3.3 Interpretation of ‘it’
Answers using the word ‘it’ should be given credit only if it is clear that the ‘it’ refers to the correct subject.
3.4 Errors carried forward, consequential marking and arithmetic errors
Allowances for errors carried forward are most likely to be restricted to calculation questions and should be shown by the abbreviation ECF or consequential in the mark scheme. An arithmetic error should be penalised for one mark only unless otherwise amplified in the mark scheme. Arithmetic errors may arise from a slip in a calculation or from an incorrect transfer of a numerical value from data given in a question.
3.5 Phonetic spelling
The phonetic spelling of correct scientific terminology should be credited unless there is a possible confusion with another technical term.
3.6 Brackets
(…..) are used to indicate information which is not essential for the mark to be awarded but is included to help the examiner identify the sense of the answer required.
3.7 Ignore/Insufficient/Do not allow
Ignore or insufficient is used when the information given is irrelevant to the question or not enough to gain the marking point. Any further correct amplification could gain the marking point. Do not allow means that this is a wrong answer which, even if the correct answer is given, will still mean that the mark is not awarded.
Question Marking Guidance Mark Comments 01.1 B : is hydrolysed in the ileum and a product of this hydrolysis is found in micelles; A : is formed by a condensation reaction between two α-glucose molecules; C : is formed by the action of DNA polymerase; B : gives a positive result in an emulsion test;
(4 x AO1) Question Marking Guidance Mark Comments 01.2 1. Facilitated diffusion of amino acid (into cell when higher concentration in lumen);
- Co-transport;
- Sodium ions actively transported from cell to blood/capillary/tissue fluid;
- Creating sodium ion concentration/diffusion gradient;
- Facilitated diffusion of amino acid into blood/capillary; 1. and 5. Accept diffusion via channel/carrier proteins for ‘facilitated diffusion’ 4 max (4 x AO1)
- Accept ‘pumped’ for transported
- and 4. Accept Na+ for sodium ion(s)
- and 4. Max 1 if ions not mentioned
Question Marking Guidance Mark Comments 02.1 1. RNA/rRNA;
- Protein; 2 (2 x AO1) Reject tRNA and mRNA Ignore amino acids Question Marking Guidance Mark Comments 02.2 1. DNA has deoxyribose, mRNA has ribose;
- DNA has thymine, mRNA has uracil;
- DNA long , mRNA short;
- DNA is double stranded, mRNA is single stranded;
- DNA has hydrogen bonds, mRNA has no hydrogen bonds OR DNA has (complementary) base pairing, mRNA does not; Must be comparisons Ignore splicing/introns 4 max (4 x AO1) 4. Accept ‘double helix’ for ‘double stranded’ and ‘single helix’ for ‘single stranded’ Question Marking Guidance Mark Comments 03.1 Flagellum/flagella; 1 (AO1) Question Marking Guidance Mark Comments 03.2 1. 3D with SEM, but 2D with TEM OR (Only) surface visible with SEM, but internal structures visible with TEM;
- (Because) electrons deflected/bounce off (using SEM) OR Electrons transmitted/pass through (using TEM);
(2 x AO1)
- Accept Resolution is lower (with SEM)
Question Marking Guidance Mark Comments 03.3 Shorter wavelength between electrons Accept ‘of electrons’ OR ‘of electron beam’ OR for ‘between electrons’ Longer wavelength in light (rays); (^1) Reject Electron (AO1) microscope has a shorter wavelength Reject Light microscope has a longer wavelength Question Marking Guidance Mark Comments 03.4 Mark in pairs: 1 and 2 OR 3 and 4
- Measure (length of structure) and divide by magnification;
- Correct conversion from measured length to μm, either × 10 000 from cm OR × 1000 from mm;
- Measure (length of structure) and divide by (image) length of scale bar;
- Multiply by actual length of scale bar;
(2 x AO1)
- Accept correct equation making reference to a measurement Question Marking Guidance Mark Comments 03.5 1. Circular DNA (molecule in cytoplasm);
- Murein cell wall OR Peptidoglycan cell wall OR Glycoprotein cell wall;
- Small(er)/70S ribosomes (in cytoplasm); 2 max (2 x AO1) Accept mesosome
Question Marking Guidance Mark Comments 03.6 1. Capsid;
- Reverse transcriptase;
- RNA genome;
- Envelope; 2 max (2 x AO1)
- Accept capsomere
- Ignore protein coat
- Accept ‘genetic material’ OR ‘genes’ for ‘genome’ Question Marking Guidance Mark Comments 04.1 1.^ Enters^ by^ diffusion;
- Down a concentration gradient OR From high to low pO 2 ;
- More/most across parts of body with gills;
- Gills provide a larger surface area (for absorption);
- 8.8 (kPa) over gills;
- 2.4 (kPa - rest of body surface) / 1.9 (kPa - front end before gills) / 0.5 (kPa - rear end after gills); 4 max (4 x AO3)
- Reject facilitated diffusion 1 and 2 ‘down a diffusion gradient’ = 2 marks
- Reject ‘along’ for ‘down’
- Accept description of O 2 is always higher in the water than the lugworm
- Accept Gills increase SA:volume ratio
Question Marking Guidance Mark Comments 04.2 Correct answer for 3 marks, 9.3 × 10 –^6 / (^) Accept correct 0.000 0093;;; rounding^ of^ 9.3^ x^10
- 6 MP1 – correct reading from graph (1.5) MP2 – correct rearrangement of equation (CdO 2 = 0.000 031 × their pO 2 )
(3 x AO2) MP3 – their CdO 2 × 0. OR their CdO 2 ÷ 5 Question Marking Guidance Mark Comments 04.3 1. (Measure light) absorption/transmission;
- Interpolate/draw line to curve/line then to pO 2 OR Read off (pO 2 figure) against absorbance/transmission value obtained;
(2 x AO3)
- Accept ‘absorbance’ for absorption
Question Marking Guidance Mark Comments 05.1 1. Condensation reaction between amino acids;
- (Forming) peptide bonds;
- Creating (specific) sequence/order of amino acids;
(3 x AO1)
- Accept descriptions of condensation reaction: eg loss of water Question Marking Guidance Mark Comments 05.2 (Similarity)
- Substrate fits/binds to active site OR Enzyme-substrate complex (formed); (Difference)
- Active site changes shape, but does not change in lock and key OR (Initially) active site not complementary to substrate with induced-fit, but is complementary in lock and key;
(2 x AO2)
- Reject ‘substrate changes shape’
- Accept ‘flexible’ for changes shape and ‘rigid’ for does not change Question Marking Guidance Mark Comments 05.3 Lower/reduce activation energy (needed to start 1 a reaction); (AO1) Question Marking Guidance Mark Comments 05.4 Correct answer for 2 marks = 300;; Accept for 1 mark, 2 000 000 or 2 × 10 6 (correct calculation of maltase rate per second) OR 6 × 108 ÷ 4 × 107 OR × 15 (correct division but not multiplied by 20)
(2 x AO2)
Question Marking Guidance Mark Comments 05.5 Increased maltase concentration;
(AO3)
Question Marking Guidance Mark Comments 06.1 1. (Is) charged/polar OR (Is) part of haem(oglobin);
- (So) binds/associates/loads (with) oxygen OR (So) forms oxyhaemoglobin OR (So) transports oxygen;
(2 x AO1)
1. Accept Fe 2+ OR Fe 3+ for ‘charged’
- Accept ‘carries’ for transports Question Marking Guidance Mark Comments 06.2 1. Less/no ferroportin hydrolysis/breakdown;
- (So) more ferroportin (in cell-surface membranes); 3. (So) more iron (ion) transport from cytoplasm/cell;
(3 x AO3)
- and 2. Accept ‘channel protein’ for ferroportin
- and 3. Accept ‘many’ for more
Question Marking Guidance Mark Comments 06.3 Correct answer for 2 marks = 30.52:1 / 30.5:1 / 31:1;; Accept for 1 mark, 31 (ratio not given) OR 30:1 (incorrect rounding) OR 200 (correct mass in healthy person)
(2 x AO2) OR 1526 (correct iron concentration in person with haemochromatosis) OR 6104 : 200 (correct ratio, but not simplified) Accept for 1 mark any correct ratio (not simplified) e.g. 763: or 1526:
Question Marking Guidance Mark Comments 07.1 1. Mass of cells/tissue OR Abnormal cells/tissue;
- Uncontrolled mitosis/cell division;
(2 x AO1)
- Accept idea of large number of cells in a lump/clump/cluster for ‘mass’
- Ignore growth Question Marking Guidance Mark Comments 07.2 1. Count cells in mitosis in field of view;
- Divide this by total number of cells in field of view;
- Repeat many/at least 5 times OR Select (fields of view) at random;
(3 x AO1)
- and 2. Max 1 if ‘field of view’ not mentioned
- Accept ‘multiple’ for ‘many’
- Ignore ‘several’ Ignore conversion of MI into a percentage. Question Marking Guidance Mark Comments 07.3 (^) Good indicator
- Dogs with MI > 5 have shorter survival time;
- (P value shows) difference is significant OR (P value shows) difference has low probability of being due to chance;
- Dogs with MI > 5 have grade 2 or grade 3 tumours/medium or high level cancer;
- Dogs with grade 1 tumours all have MI < 5; But
- (Some) dogs with MI < 5 could have any tumour grade/cancer level;
- So serious cancers missed;
- Only know median survival time (not the range);
- Accept dogs with MI > 5 only survive 2 months
- Accept converse for MI < 5 1 and 2. Accept for 2 marks, dogs with MI > 5 have a significantly shorter survival time 4 max (4 x AO3)
- Accept Difference not due to chance
- Ignore ‘results are significant’ or ‘results are not due to chance’
- Accept grade 2 or 3 for ‘any’ 3 max if none of points 5, 6 or 7 awarded
Question Marking Guidance Mark Comments 08.1 1. Unknown/new/different microorganisms/pathogens/microbes/bacteria (introduced);
- (these bacteria) use food/space OR (these bacteria) produce toxins;
- Ignore chemical contaminant 2 (2 x AO2)
- Accept description of competition for other resources Question Marking Guidance Mark Comments 08.2 Correct answer, for 2 marks = 480 000;; Accept for 1 mark, 96 000 (correct number mm
- 3 ) 120 (correct number in 0.000 25 mm^3 undiluted) OR any one of: 3 0.2 ×5 15 (correct^ dilution^ factor) OR Evidence of dividing by 0.000 25
(2 x AO2) 4.8 x 105 = 2 marks
Question Marking Guidance Mark Comments 08.3 Correct answer for 3 marks, 3 bars given
- Correct labelling of x axis; eg culture 1 , culture 2 and culture 3 OR 1,2,3 and (bacterial) culture;
- Height of culture 2 bar about one fifth height of culture 1 bar; 3. Height of culture 3 bar higher than culture 2 bar and lower than culture 1 bar; If 2 bars given OR if histogram given OR if graph given, accept for 2 marks,
- Correct labelling of x axis;
- Correct relative height of 2 bars/coordinates; eg height of culture 2 about one fifth height of culture 1 OR height culture 3 above height of culture 2 If no bar chart/histogram/graph given, accept for 1 mark,
- Correct labelling of x axis;
(3 x AO2) For labelling of x axis Accept ‘no substance’ for culture 1 Accept ‘substance J ’ for culture 2 Accept ‘substance K ’ for culture 3 Accept ‘substance’ for culture
Question Marking Guidance Mark Comments 09.1 1. Fetal blood has more oxygen OR Fetal blood has less carbon dioxide;
- (Because) gas exchange occurs in the placenta OR Gas exchange does not occur in (fetal) lungs; 1. Accept converse for references to mother’s pulmonary artery 2 (2 x AO2)
- Accept fetal blood is oxygenated
- Accept high for ‘more’ OR low for ‘less’
- Ignore affinity Question Marking Guidance Mark Comments 09.2 1. (IgG) antibodies (from mother) are complementary/bind specifically;
- To pathogens/antigens crossing the placenta;
- Giving passive immunity (in fetus) OR Stopping symptoms forming (in fetus) OR Giving immediate/rapid protection (in fetus);
(3 x AO2)
- Accept Antibodies bind with antigens / antigen-antibody complex Question Marking Guidance Mark Comments 09.3 (Against measles)
- (To achieve) herd immunity to reduce spread; (Against tetanus)
- No herd immunity OR Skin wounds are common (in children); 1.Accept ‘herd effect’ for herd immunity 2 (2 x AO2)
- Accept Only protects the individual
Question Marking Guidance Mark Comments 09.4 Accept ‘more Reduced vaccination (in children) OR
(AO2)
unvaccinated individuals entering the country/ population’ virus has mutated; (^) Reject disease mutated Question Marking Guidance Mark Comments 09.5 1. (Production of) more memory cells;
- (So) higher concentration of antibodies (in blood) OR (So) more rapid production of antibodies (on further infection);
(2 x AO2) Ignore active immunity
- Accept More antibodies (in blood)